Eighteen patients with angioimmunoblastic lymphadenopathy with dysproteinemia (AILD) have been analyzed by reviewing all available biopsy, laboratory, and clinical data. Because of features suggesting the presence of circulating immune complexes (CIC), CIC serial sample determinations were performed
Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinemia with cyclosporin A
โ Scribed by Tohru Murayarna; Shion Lmoto; Tetsuya Takahashi; Mitsuhiro Ito; Sachiko Matozaki; Toshitaro Nakagawa
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 463 KB
- Volume
- 69
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
The treatment of Factor VIII inhibitors remains controversial and no standard therapy exists. We describe in this report two consecutive patients with this inhibitor that responded to cyclosporin. Clinical improvement of the bleeding diathesis, a return to normal of the PTT, a decrease in the level
It has been suggested that cyclosporin A might be of some benefit to patients with Crohn's disease. The clinical response and side-effects of cyclosporin A in Crohn's disease are described in a series of 13 adults. The majority of patients had ileal disease and all but one were started on an initial